5-aza-CdR inhibited nuclear AID expression through ubiquitin-proteasome degradation, thus exerting a cytotoxic effect in AID-positive hematopoietic cancers. This evidence concerns the gene AICDA and hematopoietic and lymphoid cell neoplasm.